Discuss Cytokinetics Inc.
Cytokinetics Inc.
WKN: A1W1KK / Symbol: CYTK / Name: Cytokinetics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
54,00 €
3,85 %
Cytokinetics (NASDAQ:CYTK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $87.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at Truist Financial Corporation from $84.00 to $92.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at Royal Bank Of Canada from $95.00 to $101.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Cytokinetics (CYTK) had its price target raised by Needham & Company LLC from $84.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Cytokinetics (CYTK) had its price target raised by Leerink Partners from $83.00 to $84.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Cytokinetics (CYTK) had its "outperform" rating reaffirmed by Leerink Partners.
Ratings data for CYTK provided by MarketBeat
Cytokinetics (CYTK) had its price target raised by JPMorgan Chase & Co. from $74.00 to $75.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Neueste Beiträge
UBS_Group_AG in AnaptysBio Inc diskutieren